Closed
Genome Prairie — Canadian Biotechnology Innovation and Commercialization (CBIC) Initiative
Funding for genomics innovation partnerships
Last Update: April 9, 2026
Funding available
$ 100,000 - $ 2,000,000
Timeline
- Closing date : March 17, 2025
Location
Alberta, Manitoba, Saskatchewan, Canada
Overview
This program supports public-private genomics and biotechnology R&D partnerships in Canada, with up to $2 million in Genome Canada funding. It targets innovation, commercialization, and projects that can generate social and economic benefits.
/100
Opportunity Score
Moderate potential, but conditions must align.
At a glance
Funding available
Financing goals
- Develop strategic partnerships
- Develop a new product or service
- Conduct research and development activities
Eligible Funding
- Maximum amount : 2,000,000 $
- Minimum amount : 100,000 $
- Up to 33% of project cost
Timeline
- Closing date : March 17, 2025
Eligible candidates
Eligible Industries
- Manufacturing
- Professional, scientific and technical services
- Health care and social assistance
Location
- Alberta, Manitoba, Saskatchewan
Legal structures
- Non-profit
- Public or Parapublic institution
- For-profit business
Annual revenue
- All revenue ranges
Organisation size
- All organization sizes
Audience
- Indigenous Peoples
- Persons with Disabilities
- Other Racialized Persons
- Black Canadians
- 2SLGBTQI+
- Canadians
- Women
Non-profit candidates
Sector of operation
- Higher Education
- Research
- Hospitals and Rehabilitation
- Other Health Services
- Economic, Social and Community Development
Target groups
- Indigenous peoples
- People with disabilities
- Women & girls
- LGBTQ+ community
- Business owners / entrepreneurs
- Academia / students
- Minority groups
Revenue structures
- All structures
Scope
- Municipal
- Regional
- Provincial
- National
- International
Next Steps
1
Determine your project
2
Validate your eligibility
Activities funded
- Innovation research and development from invention to prototype demonstration
- Development of genomics and biotechnology products, processes, or services
- Commercialization-oriented public-private R&D projects
Documents Needed
- Letter of intent
- Full application
- Project research, development, and commercialization plan
- Project budget
- Data release and resource sharing plan
Eligibility
Who is eligible?
- Canadian university or college researchers
- Affiliated non-commercial research entities such as hospitals and research institutes
- Canadian for-profit entities
- Foreign for-profit entities with business operations in Canada
- Industry consortia and selected non-profit organizations
Who is not eligible
- Discovery research projects
- Commercial launches of already developed technology
- Low-risk R&D suited to capital markets
- Projects or services normally funded solely by the receptor
Eligible expenses
- Project equipment items up to $100,000 each, subject to program limits
- External services needed for the project, subject to program limits
Ineligible Costs and Activities
- Discovery research
- Commercial launches of already developed technology
- Low-risk R&D that can be serviced by capital markets
- Projects or services normally funded solely by the receptor
Eligible geographic areas
- Canada
Processing and Agreement
- Letter of intent is reviewed first for eligibility
- Eligible full applications are reviewed by external experts
- The Genome Canada Oversight and Review Committee reviews the expert assessments
- The Board of Directors makes the final funding decision
- Funded projects must submit periodic progress information and reports
Additional information
- Applicants must acknowledge that all flow-of-funds conditions, including contribution and IP agreements, must be secured by March 17, 2025 at 9:00 AM EDT.
- Projects involving Indigenous research should include a plan for engagement and follow relevant ethical and OCAP principles.
- Genome Canada’s data release and resource sharing policies apply, and an exemption may be requested in some cases.
- Funding release depends on a legally binding IP agreement signed by all concerned parties.
Frequently Asked Questions about the Genome Prairie — Canadian Biotechnology Innovation and Commercialization (CBIC) Initiative Program
What is the Genome Prairie — Canadian Biotechnology Innovation and Commercialization (CBIC) Initiative?
This program supports public-private genomics and biotechnology R&D partnerships in Canada, with up to $2 million in Genome Canada funding. It targets innovation, commercialization, and projects that can generate social and economic benefits.
How much funding can be received?
Genome Prairie — Canadian Biotechnology Innovation and Commercialization (CBIC) Initiative Funds up to 33% of admissible expenses, capped at $2,000,000 per project.
Who is eligible for the Genome Prairie — Canadian Biotechnology Innovation and Commercialization (CBIC) Initiative program?
To be eligible for the Genome Prairie — Canadian Biotechnology Innovation and Commercialization (CBIC) Initiative program, you must:
Innovation R&D project
Researcher and receptor partnership
Canadian social or economic benefit
What expenses are eligible under Genome Prairie — Canadian Biotechnology Innovation and Commercialization (CBIC) Initiative?
Innovation research and development from invention to prototype demonstration
Development of genomics and biotechnology products, processes, or services
Commercialization-oriented public-private R&D projects
Where is the Genome Prairie — Canadian Biotechnology Innovation and Commercialization (CBIC) Initiative available?
The Genome Prairie — Canadian Biotechnology Innovation and Commercialization (CBIC) Initiative program is available the province of Alberta, Manitoba, Saskatchewan.
Is the Genome Prairie — Canadian Biotechnology Innovation and Commercialization (CBIC) Initiative a grant, loan, or tax credit?
Genome Prairie — Canadian Biotechnology Innovation and Commercialization (CBIC) Initiative is a Researchers And Facilities
Who are the financial supporters of the Genome Prairie — Canadian Biotechnology Innovation and Commercialization (CBIC) Initiative?
Genome Prairie — Canadian Biotechnology Innovation and Commercialization (CBIC) Initiative is funded by Genome Canada, Genome Prairie